Literature DB >> 16288291

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Lionel Larue1, Alfonso Bellacosa.   

Abstract

Epithelial-mesenchymal transition (EMT) is an important process during development by which epithelial cells acquire mesenchymal, fibroblast-like properties and show reduced intercellular adhesion and increased motility. Accumulating evidence points to a critical role of EMT-like events during tumor progression and malignant transformation, endowing the incipient cancer cell with invasive and metastatic properties. Several oncogenic pathways (peptide growth factors, Src, Ras, Ets, integrin, Wnt/beta-catenin and Notch) induce EMT and a critical molecular event is the downregulation of the cell adhesion molecule E-cadherin. Recently, activation of the phosphatidylinositol 3' kinase (PI3K)/AKT axis is emerging as a central feature of EMT. In this review, we discuss the role of PI3K/AKT pathways in EMT during development and cancer with a focus on E-cadherin regulation. Interactions between PI3K/AKT and other EMT-inducing pathways are presented, along with a discussion of the therapeutic implications of modulating EMT in order to achieve cancer control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288291     DOI: 10.1038/sj.onc.1209091

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  489 in total

1.  Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells.

Authors:  Yoshihiro Takeyama; Mitsuo Sato; Mihoko Horio; Tetsunari Hase; Kenya Yoshida; Toshihiko Yokoyama; Harunori Nakashima; Naozumi Hashimoto; Yoshitaka Sekido; Adi F Gazdar; John D Minna; Masashi Kondo; Yoshinori Hasegawa
Journal:  Cancer Lett       Date:  2010-05-07       Impact factor: 8.679

2.  A single-base substitution in the seed region of miR-184 causes EDICT syndrome.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

3.  Mammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.

Authors:  Yanhong Zhang; Wensheng Yan; Yong Sam Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

4.  An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis.

Authors:  Pamela A Smith; David Merritt; Leah Barr; David A Thorley-Lawson
Journal:  Genes Cancer       Date:  2011-11

Review 5.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

Review 6.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

7.  YKL-40 promotes the migration and invasion of prostate cancer cells by regulating epithelial mesenchymal transition.

Authors:  Hailong Hao; Lei Wang; Huiqing Chen; Liwu Xie; Tao Bai; Hongyu Liu; Dongwen Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

8.  MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.

Authors:  Chandra Bartholomeusz; Xuemei Xie; Mary Kathryn Pitner; Kimie Kondo; Ali Dadbin; Jangsoon Lee; Hitomi Saso; Paul D Smith; Kevin N Dalby; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2015-09-17       Impact factor: 6.261

9.  Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.

Authors:  Kesarin Busaranon; Preeyaporn Plaimee; Boonchoo Sritularak; Pithi Chanvorachote
Journal:  J Nat Med       Date:  2015-09-18       Impact factor: 2.343

10.  Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.

Authors:  Jin Dai; Peter G Van Wie; Leonard Yenwong Fai; Donghern Kim; Lei Wang; Pratheeshkumar Poyil; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-20       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.